Similar articles

• Improving the curability of acute leukemia: pharmacologic approaches.

  Bertino JR. Bertino JR. Semin Hematol. 1991 Jul;28(3 Suppl 4):9-11. Semin Hematol. 1991. PMID: 1780760 Review. No abstract available.
• The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.

  Urban C, Benesch M, Lackner H, Schwinger W, Kerbl R, Gadner H. Urban C, et al. Klin Padiatr. 1997 Jul-Aug;209(4):235-42. doi: 10.1055/s-2008-1043956. Klin Padiatr. 1997. PMID: 9293456
• Optimal asparaginase therapy.

  Holcenberg J. Holcenberg J. J Pediatr Hematol Oncol. 2004 May;26(5):273-4. doi: 10.1097/00043426-200405000-00001. J Pediatr Hematol Oncol. 2004. PMID: 15111775 No abstract available.
• [Efficiency of the ALL-MB-2002 protocol in children with acute lymphoblastic leukemia].

  Rumiantseva IuV, Karachunskiĭ AI, Aleĭnikova OV, Fechina LG, Shamardina AV, Litvinov DV, Ponomareva NI, Boĭchenko EG, Dudkin SA, Streneva OV, Kondratchik KL, Mansurova EG, Minkina LM, Lapotentova ES, Iniushkina EV, Iudina NB, Pavlova GP, Zhukovskaia EV, Khlebnikova OP, Lagoĭko SN, Basharova EV, Denisov RE, Zlobina VD, Banshchikova ES, Aslanian KS, Kondakova EV, Tselousova EV, Miakova NV, Turobova TV, Ryskal' OV, Chipsanova NF, Varfolomeeva SR, Rumiantsev AG. Rumiantseva IuV, et al. Ter Arkh. 2010;82(7):11-9. Ter Arkh. 2010. PMID: 20853603 Clinical Trial. Russian.
• High-dose chemotherapy in adult acute lymphoblastic leukemia.

  Hoelzer D. Hoelzer D. Semin Hematol. 1991 Jul;28(3 Suppl 4):84-9. Semin Hematol. 1991. PMID: 1780759 Review. No abstract available.